From: A systematic review of the epidemiology of hepatitis A in Africa
Author, Year (Citation) | Study Design | Year(s) of Data Collection | Country | Population | Sample Size (n) | Outcome Measures | Study Objective |
---|---|---|---|---|---|---|---|
Abdulla et al., 2010 [22] | Cross-sectional | 2006 to 2008 | General Africa | Children & adolescents | 29 | IgG | To determine the prevalence of acute hepatitis A virus infection and immunity among internationally adopted children |
Afegbua et al., 2013 [27] | Cross-sectional | 2009 | Nigeria | Children & adolescents | 403 | IgG | To determine seroprevalence of HAV among schoolchildren and adolescents in Kaduna State and identify factors associated with seropositivity |
Al-Aziz et al., 2008 [28] | Cohort | 2008 | Egypt | Children & adolescents | 296 | IgG | To determine the seroprevalence of HAV antibodies among group of children |
Blanchi et al., 2014 [23] | Cohort | 2009 to 2012 | General Africa | Children | 146 | IgM | To describe infectious diseases in internationally adopted children |
Bonney et al., 2013 [29] | Cross-sectional | 2008 to 2011 | Ghana | All ages | 285 | IgM | To determine if viral hemorrhagic fevers and viral hepatitides contribute to hospital morbidity in the Central and Northern parts of Ghana |
Bouskraoui et al., 2009 [30] | Cross-sectional | 2005 to 2006 | Morrocco | Children & adolescents | 150 | IgG | To assess the prevalence of viral hepatitis A infection in febrile icteric children and to examine the main risk factors of transmission |
Burrous et al., 2010 [31] | Cross-sectional | 2006 to 2008 | Morrocco | Children & adolescents | 129 | IgM | To assess the prevalence of viral hepatitis A infection in febrile icteric children and to examine the main risk factors of transmission |
El-Karasksy et al., 2008 [32] | Cohort | 2005 | Egypt | Children & adolescents | 172 | IgG | To determine the prevalence of anti-hepatitis A virus antibodies among 172 children with chronic liver disease |
Ellis et al., 2008 [33] | Cohort | 2008 | Mali | Children | 36 | IgM | Phase 1 study in Malian children of the blood stage malaria vaccine |
Enoch et al., 2019 [21] | Cross-sectional | 2009 to 2015 | South Africa | Children | 482 | IgG | To determine the seroprevalence of hepatitis A infection in the Western Cape Province of South Africa |
Forbi et al., 2012 [34] | Cohort | 2012 | Cameroon | Children | 78 | IgM | To undertake genetic analysis of the hepatitis A virus associated with cases of acute diarrhea among children under five in Cameroon |
Forbi et al., 2012_2 [35] | Cross-sectional | 2006 | Nigeria | Adults | 114 | IgM | To investigate HAV strains among apparently healthy adult Nigerian subjects |
Guenifi et al., 2017 [36] | Cross-sectional | 2010 to 2011 | Algeria | Children | 1061 | IgG | To estimate the seroprevalence of hepatitis A virus infection in the district of Setif |
Ikobah et al., 2015 [37] | Cross-sectional | 2012 | Nigeria | Children & adolescents | 406 | IgG | To determine the seroprevalence and predictors of viral hepatitis A in children aged 1 to 18 years |
Jablonka et al., 2017 [38] | Cross-sectional | 2015 | General Africa | All ages | 55 | IgG | To determine the seroprevalence of anti-HAV IgG in refugees in Germany |
Klouwenberg et al., 2011 [39] | Cohort | 2011 | Kenya | Children | 222 | IgM | To determine the temporal pattern of a co-infection of P. falciparum malaria and acute HAV in a cohort of Kenyan children under the age of five |
Lopes et al., 2017 [40] | Cross-sectional | 2015 | South Africa | All ages | 300 | IgG | To determine the seroprevalence of HAV and HEV antibodies in blood donors giving at the Western Province Blood Transfusion Service |
Louati et al., 2009 [41] | Cross-sectional | 2007 | Tunisia | Adults | 376 | IgG | To assess hepatitis A virus seroprevalence in blood donors from South Tunisia in two periods; 200 and 2007 |
Majori et al., 2008 [26] | Cross-sectional | 2008 | General Africa | All ages | 182 | IgG & IgM | To assess the seroprevalence of viral hepatitis infections in sub-Saharan immigrants living in Italy |
Mazanderani et al., 2018 [11] | Cross-sectional | 2005 to 2015 | South Africa | All ages | 501083 | IgG & IgM | To assess seroprevalence rates among specimens tested for HAV serology within South Africa’s public health sector |
Mphaka et al., 2016 [42] | Cross-sectional | 2016 | South Africa | Children & adolescents | 46 | IgM | To respond to an increase in blood samples testing positive for HAV IgM |
Murchiri et al., 2012 [43] | Cross-sectional | 2007 to 2008 | Kenya | Adults | 100 | IgM | To determine seroprevalence of HAV, HBV HCV and HEV among patients with acute hepatitis in Nairobi Kenya |
Nagu et al., 2008 [44] | Cross-sectional | 2006 | Tanzania | Adults | 260 | IgM | To determine the prevalence and predictors of viral hepatitis co-infection among HIV-infected individuals presenting at the HIV care and treatment clinics in the country |
Neffatti et al., 2017 [45] | Cross-sectional | 2014 to 2015 | Tunisia | Adults | 216 | IgG | To supplement lacking data on hepatitis A and E from rural areas of South Tunisia |
Ogefere et al., 2016 [46] | Cross-sectional | 2016 | Nigeria | All ages | 200 | IgM | To determine the seroprevalence of anti-HAV IgM in an at-risk population in Benin City and to identify the social, demographic and other risk factors |
Raabe et al., 2014 [24] | Cross-sectional | 2014 | General Africa | Children | 656 | IgM | To assess the need to recommend routine HAV vaccination in internationally adopted children |
Rabenau et al., 2010 [47] | Cohort | 2007 | Lesotho | Adults | 205 | IgG | To screen international adoptees for acute HAV infection |
Rezig et al., 2008 [48] | Cross-sectional | 2008 | Algeria | Children & adolescents | 3357 | IgG | To assess the seroprevalence of coinfecting viruses in a cohort of 205 HIV-infected individuals |
Smahi et al., 2009 [49] | Cross-sectional | 2006 | Algeria | Children | 252 | IgG | To determine the seroprevalence of hepatitis A and E infections |
Sule et al., 2013 [50] | Cross-sectional | 2010 to 2011 | Nigeria | All ages | 91 | IgG | To determine the prevalence of anti-hepatitis A virus IgG antibody and associated factors among residents of Osogbo |
Tantawy et al., 2012 [51] | Case-control | 2009 to 2010 | Egypt | Children & adolescents | 182 | IgG | To evaluate the seroprevalence of hepatitis A in Egyptian patients with haemophilia A |
Traore et al., 2012 | Cross-sectional | 2010 to 2012 | Burkina Faso | Adults | 91 | IgG & IgM | To assess the seroprevalence of antibodies to both HAV and HEV in central Burkina Faso in the absence of a recorded hepatitis epidemic |